These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14411480)

  • 21. [A new inhibitor of thromboplastin generation produced during the proteolytic degradation of fibrinogen].
    NIEWIAROWSKI S; LATALLO Z; STACHURSKA J
    Sangre (Barc); 1959; 30():376-8. PubMed ID: 14427140
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 23. CLINICAL ANESTHESIA CONFERENCE.
    MARK LC; MARX GF; HENRY EL; KEPES ER; MAZZA L; TIERS FM
    N Y State J Med; 1964 Jul; 64():1860-2. PubMed ID: 14154608
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
    DE NICOLA P; ZANGAGLIA O; SOARDI F
    Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relations between haptoglobin, orosomucoid and fibrinogen].
    JAYLE MF; MARNAY A; POINTIS J
    Nouv Rev Fr Hematol; 1962; 2():483-9. PubMed ID: 13957575
    [No Abstract]   [Full Text] [Related]  

  • 26. [Some observations on the coagulation of fibrinogen].
    ASTRUP T
    Bull Soc Chim Biol (Paris); 1947; 29(4-6):391-9. PubMed ID: 18900129
    [No Abstract]   [Full Text] [Related]  

  • 27. THE ACTION OF PLASMIN ON FIBRINOGEN ADN FIBRIN. I. CHANGES IN THE N-TERMINAL RESIDUES.
    MILLS DA; COYNE R; POLLARA B; VONKORFF RW
    Biochim Biophys Acta; 1964 Jun; 86():527-34. PubMed ID: 14192904
    [No Abstract]   [Full Text] [Related]  

  • 28. INHIBITION OF THE FIBRINOGEN-PLASMIN REACTION BY OMEGA-AMINOCARBOXYLIC ACIDS AND ALKYLAMINES.
    BICKFORD AF; TAYLOR FB; SHEENA R
    Biochim Biophys Acta; 1964 Nov; 92():328-33. PubMed ID: 14249121
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of ACTH on the erythrocyte-sedimentation rate and plasma-fibrinogen and serum-protein levels in normal persons.
    FEARNLEY GR; BUNIM JJ
    Lancet; 1951 Dec; 2(6694):1113-6. PubMed ID: 14881578
    [No Abstract]   [Full Text] [Related]  

  • 30. Experiences with inhibitors to the plasmin-plasminogen system in the human subject: their modifications by thrombolysin therapy.
    SANDBERG H; TSITOURIS G; BELLET S
    Am J Cardiol; 1960 Aug; 6():432-8. PubMed ID: 14441368
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serological aspects of simple and ozenatous atrophic rhinitis].
    CORBETTA L
    Otorinolaringol Ital; 1959; 28():374-84. PubMed ID: 13811905
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of protamine on fibrinogen in vivo and in vitro].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1952 Nov; 30(41-2):997. PubMed ID: 13023943
    [No Abstract]   [Full Text] [Related]  

  • 33. IN VITRO--PRECIPITATIONS IN PLASMA BY LOW MOLECULAR WEIGHT DEXTRAN.
    KROLL J; DYBKAER R
    Scand J Clin Lab Invest; 1964; 16():31-8. PubMed ID: 14124449
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of intravenous pitocin on fibrinogen and fibrinolysin.
    SALVAGGIO AT
    Obstet Gynecol; 1960 Jun; 15():757-60. PubMed ID: 14441115
    [No Abstract]   [Full Text] [Related]  

  • 35. The reducing properties of fibrinogen; the role of SH groups in the clotting of fibrinogen.
    BAGDY D; GUBA F
    Hung Acta Physiol; 1948; 1(6):197-210. PubMed ID: 18894927
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of the origin of proteins. I. Plasma concentrations of fibrinogen in venous, arterial and medullary blood in normal and pathological subjects].
    BUGARO L; DE CASTRO B
    Haematologica; 1957; 42(4):357-68. PubMed ID: 13428166
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative studies on fibrinogen reduction in cadaveric blood].
    SCHLEYER F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1950; 211(3):292-302. PubMed ID: 14790710
    [No Abstract]   [Full Text] [Related]  

  • 38. [METABOLISM OF FIBRINOGEN].
    SOULIER JP
    Nouv Rev Fr Hematol; 1965; 5():323-7. PubMed ID: 14307704
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preparation of fibrinogen for intravenous use at a blood transfusion station].
    BILA K; FISER I; HOVEZAK V; PRINZ M
    Probl Gematol Pereliv Krovi; 1962 May; 7():43-6. PubMed ID: 13869156
    [No Abstract]   [Full Text] [Related]  

  • 40. [DETERMINATION OF BLOOD PLASMA FIBRINOGEN BY THE AGAR ELECTROPHORESIS METHOD].
    DALGELITE R; IUKHNIAVICHIUTE L; VAICHIUVENAS V
    Lab Delo; 1963 May; 9():5-8. PubMed ID: 14080969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.